Anthoula Chatzikyriakidou Selected Research

Interleukin-1 Receptor-Associated Kinases

1/2019	Association of NFKB1 -94ATTG ins/del polymorphism (rs28362491) with pemphigus vulgaris.
10/2010	A polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthoula Chatzikyriakidou Research Topics

Disease

4	Rheumatoid Arthritis 03/2018 - 09/2007
2	Primary Hyperparathyroidism 05/2023 - 01/2023
2	Neoplasms (Cancer) 05/2022 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 07/2012
2	Ankylosing Spondylitis 09/2014 - 09/2011
1	COVID-19 03/2024
1	Hypocalcemia 05/2023
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2023
1	Breast Neoplasms (Breast Cancer) 05/2022
1	Papillary Thyroid Cancer 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Carcinogenesis 11/2019
1	Pemphigus (Pemphigus Vulgaris) 01/2019
1	Skin Diseases (Skin Disease) 01/2019
1	Glaucoma 10/2018
1	Exfoliation Syndrome 10/2018
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 10/2018
1	Inflammation (Inflammations) 04/2012
1	Genetic Predisposition to Disease (Genetic Predisposition) 06/2011
1	Malaria 06/2011
1	Spondylarthropathies 06/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2008
1	Cystinuria 10/2006
1	Hyperinsulinism (Hyperinsulinemia) 02/2005
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 02/2005
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2005
1	Insulin Resistance 02/2005

Drug/Important Bio-Agent (IBA)

3	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2012
2	Interleukin-1 Receptor-Associated KinasesIBA 01/2019 - 10/2010
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 09/2014 - 06/2011
1	Calcitriol Receptors (Calcitriol Receptor)IBA 03/2024
1	methyl 4-azidophenylacetimidate (APAI)IBA 03/2024
1	Parathyroid Hormone (Parathormone)IBA 05/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Metalloproteases (Metalloproteinases)IBA 05/2022
1	transcription factor S-IIIBA 05/2022
1	Nudix HydrolasesIBA 05/2022
1	Androgen Receptors (Androgen Receptor)IBA 05/2022
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 05/2022
1	fibroblast growth factor 13IBA 05/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Desmoglein 3IBA 01/2019
1	NF-kappa B (NF-kB)IBA 01/2019
1	AutoantibodiesIBA 01/2019
1	KininsIBA 03/2018
1	Kininogens (Kininogen)IBA 03/2018
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2018
1	Kallikreins (Kallikrein)IBA 03/2018
1	Bradykinin Receptors (Bradykinin Receptor)IBA 03/2018
1	High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA 03/2018
1	Estrogen ReceptorsIBA 04/2012
1	Hormones (Hormone)IBA 04/2012
1	SelectinsIBA 04/2012
1	Semaphorins (Semaphorin)IBA 09/2011
1	HLA Antigens (Human Leukocyte Antigens)IBA 06/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2008
1	Methotrexate (Mexate)FDA LinkGeneric 09/2007
1	Folic Acid AntagonistsIBA 09/2007
1	NucleotidesIBA 10/2006
1	Insulin (Novolin)FDA Link 02/2005
1	HDL CholesterolIBA 02/2005
1	AdiponectinIBA 02/2005
1	Triglycerides (Triacylglycerol)IBA 02/2005

Therapy/Procedure

2	Therapeutics 04/2012 - 09/2007